Note: You are reading this message either because your browser is not standards-compliant, or your browser failed to load our css files.

A description of the content follows : If you were going to make your way to Stony Brook, New York on September 16th to attend Applied DNA's annual shareholder meeting, don't pack your bags just yet. The meeting has been postponed.

Current Trades In Play

Symbol Picked ST SSL
COGT $10.09 $12.77 $9.28
VOYT $0.12 $0.36 $0.05
BMSN $0.56 $1.45 $0.25
THC $4.06 $7.67 $3.17
ST Denotes Suggested Target.
SSL Denotes Suggested Stop Loss.
Click Here to View the V2K Internatinoal Video Presentation

Market Summary

Stock Market Indexes Chart
Dow 11502.51 +89.64 (+0.79%)
Nasdaq 2382.46 +20.49 (+0.87%)
Russell 2K 732.95 +0.00 (+0.00%)
S&P 500 1281.66 +10.15 (+0.79%)
S&P 100 590.55 +4.05 (+0.69%)
Quotes are delayed 20 minutes.
Free Annual ReportsFree Annual Reports

Small Cap RSS Content

The Small Cap Network content is also available via RSS feeds, viewable with an RSS or Atom capable client.

Don't miss an article. Click Here for complete instructions on how to add our RSS feeds to your Outlook or Internet Explorer.

Blog Counter

Small Cap Network Blog

7/16/2008

Applied DNA (APDN) Shareholder Meeting To Be Rescheduled

Filed under: — SmallCapNetwork Editor @ 7:20 am

Just an FYI - Applied DNA (APDN) is going to reschedule their annual shareholder’s meeting. It was going to take place on September 16th in Stony Brook, New York. The company has postponed the event though, and will release a new meeting time and location in the near future.

The September 16th meeting was for shareholders on record as of July 15th. That record date, however, will not apply for the rescheduled meeting; a new date of record will also be announced soon.

2 Comments »

  1. you had a sl @ .07. what’s your take on apdn now!

    Editor’s response: They blew it. Conceptually the idea is great. The company just can’t get anything going on the sales front though. In retrospect, maybe the concept is a little too cutting edge. I don’t know - it just never got any interest.

    Investors will give you a little time, but the company had a $15 million market cap and were stuck on sales of about $120K per quarter for the last three quarters. That’s just not going to do it.

    Comment by bb — 7/17/2008 @ 12:10 pm

  2. you had a sl @ .07 what’s you take on this dog. ever since they got their final payment for the cotton study and you thought it would bounce to .17, which I also thought, it’s been down down down. postponing the shareholders meeting was interesting as the shareholders were to vote on an option plan for mgt. @ .11

    Editor’s response: See the other entry on the same topic. (Are you the same person?)

    Comment by Anonymous — 7/17/2008 @ 12:02 pm

RSS feed for comments on this post.

Leave a comment

Line and paragraph breaks automatic, e-mail address never displayed, HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>


Click Here to View the Spicy Pickle Video Presentation

Latest Company Profile Blogs

Thu, Aug 21, 2008 @ 08:53 am
Thanks for all your comments and questions regarding this morning’s announcement that Applied DNA (APDN) was entering the anti-counterfeit wine arena. We agree - it’s a big deal, and could really boost the top and bottom line. It did raise a good question though…one we think is worth answering publicly. Richard writes… You are missing one [...]
Wed, Aug 20, 2008 @ 05:37 am
It had been a while since we heard anything from biotech company CEL-SCI (CVM), but that changed yesterday with a fat dose of encouraging news. Teva Pharmaceuticals (TEVA) has been signed as an exclusive licensee of CEL-SCI’s cancer treatment - Multikine - for Turkey and Israel. What’s interesting here is that Teva got on board even [...]
Mon, Aug 18, 2008 @ 09:57 am
If the rest of the market were up for the day I’m sure I wouldn’t even mention it. But, when one of our bulletin board stocks is making a gain in this environment, I think it deserves at least a mention….particularly when it looks like it’s trying to stage a breakout. I’m talking about our small [...]

Recent Newsletter Editions

Mon, Aug 25, 2008 @ 04:29 am
Remember what I said about a week ago regarding Voyant's RocketStream? After the company announced their technology was being used to deliver television footage of the Olympics to Taiwanese viewers, I repeated something I've said several times now.... there's a market for this product. I've added another...
Thu, Aug 21, 2008 @ 05:31 am
For centuries wine has been a profitable industry. In fact, wine so engrained into our society now, the Wine Institute (yes, a legitimate organization) estimates wine sales totaled $26 billion in the U.S. alone a couple of years ago. That's a lot of dollars up for grabs. Of course, where there's money...
Tue, Aug 19, 2008 @ 04:19 am
Could anything possibly make Michael Phelps even faster than he already is? Yeah, believe it or not, Voyant can make him even faster....in a sense. We'll get to that first, but be sure to keep reading after that. I want to take a real good look at the market - I don't like what's coming in the very short-term...